- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
2. In regulation 7 (amendment of regulation 13 (supply of investigational medicinal products for the purpose of clinical trials))—
(a)in paragraph (2), for the inserted sub-paragraph (b), substitute—
“(b)in the case of—
(i)an investigational medicinal product manufactured or assembled in the United Kingdom, the product has been manufactured or assembled—
(aa)in accordance with the terms of a manufacturing authorisation, or
(bb)in the case of assembly only, under the exemption in regulation 37;
(ii)an investigational medicinal product imported into Northern Ireland from an EEA State—
(aa)the product has been manufactured, assembled or imported into an EEA State in accordance with the terms of an authorisation referred to in Article 13 of the Directive granted by a competent authority of an EEA State, and
(bb)the production batch of investigational medicinal products of which the product is a part has been checked and certified by a qualified person pursuant to Article 13(3) and (4) of the Directive;
(iii)an investigational medicinal product imported into Northern Ireland from a country other than an EEA State, the product has been imported into Northern Ireland in accordance with the terms of a manufacturing authorisation;
(iv)an investigational medicinal product imported into Great Britain other than from Northern Ireland, the product has been imported in accordance with the terms of a manufacturing authorisation.”;
(b)in paragraph (3), in the inserted paragraph (2A)—
(i)omit “UK”;
(ii)after “marketing authorization” insert “or marketing authorisation issued by the competent authority of an EEA State in accordance with Directive 2001/83/EC”;
(c)for paragraph (5) substitute—
“(5) For paragraph (4) substitute—
“(4) The restriction in paragraph (1) shall not apply to—
(a)the sale or supply of a medicinal product in Great Britain in accordance with the terms of a UKMA(GB) or UKMA(UK), and
(b)the sale or supply of a medicinal product in Northern Ireland in accordance with—
(i)the terms of a UKMA(NI) or UKMA(UK), or
(ii)an EU marketing authorisation (as defined in the 2012 Regulations).”.”.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: